If you need an update on this week’s pharma news and select industry blog post highlights, look no further. Here is a brief round-up:
Flow Chemistry Market worth $1,216.11 Million by 2018
According to a recent report, the Flow Chemistry Market report discusses market revenue for each type of device according to applications and regions. The applications vary with respect to device along with market share. For MRT systems the applications considered are chemicals, pharmaceuticals, academic research and laboratories, bio fuels, perfume and fragrance manufacturing, nanoparticles production and others. Read more here.
Analyzing the Global Market for Active Pharmaceutical Ingredients
According to a new market research report, the global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the year 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market. Read more here.
CPhI Pharma Insights: CPhI Announces USA Market Report at InformEx
CPhI Worldwide announces the launch of the CPhI Pharma Insights USA market report. A joint venture with InformEx, the report will provide European perspectives on the accessibility, growth and export market in the USA and is designed to encourage and increase trade harmonization between the two major pharma economies of the world. Read more here.
Merger & Acquisition Trends in the Global Pharmaceutical & Biotechnology Industry
A new industry report examines the challenges posed by expiring patents, the global economic slowdown, generic competition, reduced healthcare spending, and price premium pressures, which are forcing the pharma and biotech industry to restructure and streamline strategies to increase profitability. M&As have become key for the reversal of reduced profitability by opening access to new markets while creating more revenue pools and to some extent compensating for the depletion of the R&D pipeline. Read more here.
Derek Lowe’s In the Pipeline: A New Book on Scaffold Hopping
I’ve been sent a copy of Scaffold Hopping in Medicinal Chemistry, a new volume from Wiley, edited by Nathan Brown of the Institute of Cancer Research in London. There are eighteen chapters – five on identifying and characterizing scaffolds to start with, ten on various computational approaches to scaffold-hopping, and three case histories. Read this blog post here.
Transporters in Drug Development: A Fast-Moving Field
Membrane transporters play important roles throughout drug development, from discovery to life-cycle management. Understanding their role in pharmacology and pharmacokinetics leads to new drug targets and/or delivery strategies and may even play a role in life-cycle management and refinement of treatment protocols. Read this blog post here.
What was your news highlight this week? Get in touch @amriglobalactive pharmaceutical ingredients, API, biotechnology, chemistry, CPhI, drug development, flow chemistry, Informex, M&A, pharmaceutical, scaffolds